Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesProteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
Oncogene, 11/05/09
Zhu K et al. – The data show that proteasome inhibition activates autophagy through a phospho–eIF2alpha–dependent mechanism to eliminate protein aggregates and alleviate proteotoxic stress.
Related Articles
Proteasome Inhibitors in Cancer Therapy
Current Drug Targets, 10/23/09
Relevance Score: 70%
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
Oncogene, 10/08/09
Relevance Score: 68%
The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection
Journal of Immunology, 11/13/09
Relevance Score: 67%
SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo
Clinical Cancer Research, 10/26/09
Relevance Score: 66%
BU-32: a novel proteasome inhibitor for breast cancer
Breast Cancer Research, 10/15/09
Relevance Score: 65%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2
Virchows Archiv, 11/25/09
DcR1 expression in endometrial carcinomas
Virchows Archiv, 11/25/09
Role of caspase 8 as a determinant in trail sensitivity of neuroblastoma cell lines
Pediatric Hematology and Oncology, 11/25/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
Cancer, 11/25/09
Dysfunction of natural killer cells in patients with transitional cell carcinoma
Cancer Letters, 11/25/09
Targeting Vascular Endothelial Growth Factor in Renal Cell Carcinoma
Tumor Biology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor